Cataplexy

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA approval · 2025-05-12
EMA Authorised: Xyrem (sodium oxybate) — UCB Pharma Ltd
The European Medicines Agency authorised Xyrem (sodium oxybate) for cataplexy and narcolepsy. The marketing authorization holder is UCB Phar…